Select your location

We have detected that you are here: Switzerland.
You will be redirected to the website for: SCHILLER Sales Switzerland
in: English.
Would you like to see the content for another country or in another language?

Select country
Continue

HyperQ Resting

Non-invasive diagnosis of ischaemic heart disease

Early detection of acute coronary syndrome

Chest pain is one of the main reasons for hospital emergency department visits worldwide. Early risk stratification of patients presenting with chest pain and suspected acute myocardial  schaemia or infarction is a major clinical challenge.

Resting 12-lead ECGs, a mainstay in the management of acute myocardial ischaemia, are limited by low sensitivity, especially in cases of non-ST elevation myocardial infarction and unstable angina.

Features

  • HyperQ Resting provides high accuracy, early detection and superior diagnostic value
  • Extracts additional, previously unseen data from a 3-minute resting rhythm recording
  • Suitable for emergency departments, emergency medical services, primary care clinics and telemedicine services

Availability in your market is subject to regulatory approval.